How IBM and Graticule are linking up in rare diseases Graticule Podcast Series

Julie Krommenhoek, Vice President of Global Sales for IBM Watson Health, and Dan Housman, CTO from Graticule, discuss how the two companies are collaborating. Drawing on her extensive background in pharma research and real-world data, Julie shares how a partnering approach can solve the hard problems rare disease focused therapeutics companies face due to the limited volumes of patients they can track with RWD. The discussion explores a joint vision for creating and deploying algorithms to identify undiagnosed patients to support clinical trial recruitment or digital diagnostics to increase access to precision therapies. The podcast also explores how leveraging privacy preserving linking can extend claims data with other advanced patient data such as radiology, pathology, PROs, and genetic testing. These linked data sets can enable researchers even when analyzing small populations to generate necessary evidence to measure the value of new therapeutics on medical costs, outcomes, and patient experience in rare cohorts.